UnitedHealth Group Incorporated (UNH) price prediction
We do not issue point price predictions. Instead, our analysis anchors UNH to a composite fair-value range of $230–$450 (midpoint $340, current price $378) and a probability-weighted bull/base/bear distribution that resolves to a weighted price target of $339.99 and a weighted return of -10.1%.
Bull, base and bear price targets
Bull case (probability 20%): target $449.63, implied return +18.9%. Base case (probability 60%): target $339.99, implied return -10.1%. Bear case (probability 20%): target $230.47, implied return -39.0%.
These are not points-on-a-chart guesses. Each scenario is built from explicit revenue, margin, and capital-allocation assumptions, and discounted at 6.03%. Probability weights are calibrated to UnitedHealth Group Incorporated's mature compounder archetype — the bull tail is fatter for hyper-growth names, thinner for mature compounders, and inverted for cyclicals near peak.
Probability-weighted expected return
Folding bull/base/bear into a single weighted view, UNH's probability-weighted price target is $339.99 and the weighted return is -10.1%. The asymmetry signal — the gap between weighted return and base-case return — is $340.00 composite expected value..
Asymmetry matters more than the headline return. A 10% expected return with a 30%-bear/15%-bull dispersion is a different bet than a 10% expected return with a 10%-bear/12%-bull dispersion. The full report walks through both for UNH.
What our forecast deliberately does not do
We do not publish twelve monthly price targets across a calendar year, we do not back-test indicators on past prices, and we do not anchor any number to "analyst consensus" — the consensus is a useful sanity check, not a target. If our composite fair value differs from the analyst consensus by more than 30%, the full report runs a consensus-divergence diagnostic instead of silently revising toward the crowd.
What we do publish: the 5×5 Ke-versus-terminal-growth sensitivity matrix, five formal stress tests with quantified fair-value impact, an earnings decision tree if reporting is within 60 days, and explicit position-management checkpoints. Together those answer "what if my view is wrong?" — a more useful question for an investor than "what's the price next month?".
How to use this for UNH
Anchor on the fair-value range ($230–$450), size against the bull/base/bear distribution, and define a kill-scenario list before entry. Our current rating for UNH is Reduce; rating-band changes are the trigger for re-sizing, not for trading the noise around them.
For the canonical version of this answer — including the sensitivity matrix, scorecard, and full assumption ledger — see the full report at /stocks/unh/analysis.
Frequently asked questions
What is the price prediction for UNH?
We anchor UNH to a fair-value range of $230–$450, with a midpoint of $340. The probability-weighted price target is $339.99 (weighted return -10.1%). We do not issue single-point price predictions.
What is the bull-case target for UNH?
The bull case (probability 20%) targets $449.63, an implied return of +18.9%.
What is the bear-case target for UNH?
The bear case (probability 20%) targets $230.47, an implied return of -39.0%.
Do you publish a 12-month UNH price target?
No. We publish a fair-value range, a bull/base/bear distribution with explicit probabilities, and a probability-weighted expected return — not a single 12-month point.
Research for educational purposes. Not personalised investment advice. See the full UNH report for the canonical evidence.